These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1297606)

  • 1. Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
    di Cianni G; Benzi L; Ciccarone AM; Cecchetti P; Navalesi R
    Diabete Metab; 1992; 18(6):468-9. PubMed ID: 1297606
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of combined therapies in treatment of secondary failure to glyburide.
    Trischitta V; Italia S; Mazzarino S; Buscema M; Rabuazzo AM; Sangiorgio L; Squatrito S; Vigneri R
    Diabetes Care; 1992 Apr; 15(4):539-42. PubMed ID: 1499473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up.
    Clauson P; Karlander S; Steen L; Efendic S
    Diabet Med; 1996 May; 13(5):471-7. PubMed ID: 8737030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
    Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.
    Riddle M; Hart J; Bingham P; Garrison C; McDaniel P
    Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the efficiency of ultralente insulin and NPH insulin combined with sulfonylurea in type 2 diabetes patients with secondary tolerance to sulfonylurea. Possible selection criteria].
    Sangiorgio L; Rabuazzo MA; Cordaro G; Grasso G; Condorelli L; Lunetta M
    Minerva Endocrinol; 1996 Jun; 21(2):47-52. PubMed ID: 9026680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.
    Yki-Järvinen H; Dressler A; Ziemen M;
    Diabetes Care; 2000 Aug; 23(8):1130-6. PubMed ID: 10937510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.
    Umpierrez GE; Clark WS; Steen MT
    Diabetes Care; 1997 Apr; 20(4):479-83. PubMed ID: 9096964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
    DeFronzo RA; Goodman AM
    N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects.
    Torella R; Salvatore T; Cozzolino D; Giunta R; Quatraro A; Giugliano D
    Diabete Metab; 1991; 17(5):443-7. PubMed ID: 1752344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K; O'Dorisio TM; Falko JM
    Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with noninsulin-dependent diabetes mellitus.
    Kitabchi AE; Soria AG; Radparvar A; Lawson-Grant V
    Am J Med Sci; 1987 Jul; 294(1):10-4. PubMed ID: 3605188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic control and insulin secretion in diabetic patients treated with glibenclamide-phenformin combination].
    Fedele D; Tiengo A; Muggeo M; Garotti C; Crepaldi G
    Clin Ter; 1975 Nov; 75(3):273-80. PubMed ID: 819203
    [No Abstract]   [Full Text] [Related]  

  • 17. Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.
    Groop LC; Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Schalin-Jäntti C; Eriksson JG
    Diabetes Care; 1992 Jul; 15(7):831-4. PubMed ID: 1516500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of sulfonylurea and sulfonylurea-benfluorex therapy in patients with type 2 diabetes treated with commercial sulfonylurea-biguanide combinations].
    Di Cianni G; Benzi L; Ciccarone AM; Cecchetti P; Giannarelli R; Penno G; Navalesi R
    Clin Ter; 1990 Aug 15-31; 134(3-4):187-91. PubMed ID: 2147619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.
    Soneru IL; Agrawal L; Murphy JC; Lawrence AM; Abraira C
    Diabetes Care; 1993 Jun; 16(6):896-901. PubMed ID: 8325203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
    Nathan DM; Roussell A; Godine JE
    Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.